The process of getting regulatory clearances for India’s indigenous Covid vaccine, Covaxin, is at a puzzling stage. While Bharat Biotech, the vaccine manufacturer, has been unable to present a strong enough case for an emergency...
from Times of India Opinion https://ift.tt/319xoO9
No comments:
Post a Comment